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Nocturnal Blood Glucose Profiles in
Patients with Type Diabetes Mellitus
on Multiple 
Regimens
Daily Insulin Injection
G. Vervoort3, H.M.G. Goldschmidt^ L.G. van Doornc
Department o f  ^ General Internal Medicine, University Hospital 
Nijmegen, Departments o f hClinical Chemistry and internal 
Medicine> Maria Hospital, Tilburg, The Netherlands
The aim of the study was to examine nocturnal blood glucose profiles in Type 1 diabetic 
patients on multiple (5=4) daily insulin injections. Nocturnal blood glucose profiles were 
evaluated in 31 patients collecting blood samples half-hourly from 23.00 till 07.30 h, 
while they were asleep. Nocturnal episodes of hypoglycaemia (blood glucose < 3 .0  mmol 
I“1) occurred in 29 % of these nights; 67 % of episodes were asymptomatic. In the early 
night (23.00-01.00 h), five episodes occurred with a median duration of 1 h. In the early 
morning (04.00-07.30 h) seven episodes occurred with a median duration of 3 h. No 
hypoglycaemia was noted from 01.00 to 04.00 h. Bedtime glucose levels appeared to 
predict 'early night' hypoglycaemia but not 'early morning' hypoglycaemia. Fasting glucose 
levels <5 .5  mmol l"1 were indicative of preceding 'early morning' hypoglycaemia. There 
was a large intra-individual variation in nocturnal blood glucose profiles. It is concluded 
that daily monitoring of bedtime and fasting blood glucose levels may be both more 
reliable and convenient for the prevention of nocturnal hypoglycaemia than periodic 
testing of blood glucose at 03,00h as is often advised. Setting a target of > 5 .5  mmol I 1 
for fasting blood glucose may decrease the frequency of nocturnal hypoglycaemia.
key w o r d s  Nocturnal hypoglycaemia IDDM
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Intensive insulin therapy Self-
Introduction
Patients with Type 1 (insulin-dependent) diabetes mellitus 
are at constant risk of treatment-induced hypoglycaemia,1 
Intensifying insulin therapy has been associated, although 
not consistently, with an increased incidence of this 
com plication, particularly during the night.2”7 Nocturnal 
hypoglycaemia is traumatic for both diabetic patients 
and their relatives. Warning symptoms may not occur, 
so that initially mild hypoglycaemia may progress into 
more severe hypoglycaemia, requiring intervention of 
others.7/8 It has been suggested that nocturnal hypoglycae­
mia may induce hypoglycaemia unawareness, which in 
turn increases the risk of severe hypoglycaemia at 
any time during the day.8-12 Meticulous prevention 
of hypoglycaemia (including nocturnal) is capable of 
reversing hypoglycaemia unawareness, even in long­
standing diabetes.13'14 Furthermore, a variety of non­
specific symptoms like fatigue, irritability and headache 
have been associated with nocturnal hypoglycaemia. 
Strict avoidance of nocturnal hypoglycaemia should be 
one of the cornerstones of intensive insulin therapy.
Most of the advice given to patients in order to prevent
nocturnal hypoglycaemia is based on extrapolation of 
scarce data obtained from studies with infrequent noctur­
nal blood glucose measurements in conventionally treated 
diabetic patients.1 r,“*!n To our knowledge, only one 
report concerning nocturnal hypoglycaemia in intensively 
treated Type 1 diabetes has been published.21 In order 
to extend these few observations w e  performed a study 
in which w e  measured detailed nocturnal blood glucose 
profiles in Type 1 diabetic patients on m ultip le (5=4) 
daily insulin injections.
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Patients and Methods
Thirty-one Type 1 diabetic patients, all treated with 
short-acting insulin at least three times a day and 
intermediate-acting insulin at night were random ly selec­
ted from the population of the diabetes outpatient clinic 
of the M aria Hospital Tilburg. All patients had been 
stable for more than 1 year on multiple daily injection 
therapy. They had all received intensive education 
including the use of simple algorithms to correct (heir 
blood glucose levels according to Schiffrin,22 w ith  goals 
of therapy similar to those of the D C C T .6,7 NPH-insulin  
dosage was based upon fasting blood glucose and 03 .00  
h blood glucose concentrations. Informed consent was 
obtained from all patients and the study was approved 
by the medical ethical committee of the M aria  Hospital
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Tilburg, The Netherlands. The clinical data of the patients 
< are shown in Table I .
All patients were admitted to the hospital at 20.00 h,
> after their evening meal, on a normal working day. An 
antecubital intravenous cannula was inserted to take 
blood samples without awakening the patients at night; 
the cannula was kept patent by infusion of 0.9 % saline. 
In the evening, patients were free to snack as if they 
were at home. They made their own decisions about 
insulin dose and measuring their blood glucose. NPH 
insulin was given subcutaneously in the thigh at 23.00 
h. Patients were instructed to report symptoms of 
hypoglycaemia any time during the study. Only sympto­
matic hypoglycaemia was treated by the observers. 
Between 23.00 and 07.30 h venous blood samples were 
drawn into Na-fluoride/K-oxalate bottles half-hourly, 
while the patients were asleep. The samples were 
analysed within 2 h by a glucose oxidation method.-' 
Blood glucose concentrations were not known to patients 
or observers during the study period.
Blood glucose levels were measured during 45 patient- 
nights in 31 Type 1 diabetic patients. Six patients were 
observed more than one night in order to get some
' information about the intra-individual variability of noc-
i
turnal blood glucose profiles. Analysis of the blood 
glucose profiles is based on the data of the first night of 
these 6 patients and the other 25 patient-nights (n = 31). 
HbAlt was assayed by an HPLC method (reference 
values 4.0-6.1 %).
Values of p <  0,05 were considered to be statistically sig­
nificant.
1
Statistical Analysis
Comparison for means between subjects was performed 
using unpaired /-test for normally distributed data and 
Mann-Whitney U-test for non-normally distributed data. 
Linear regression (Pearson) was used for calculation of 
the correlation coefficient. Results are expressed as mean 
±5D or median (range) when non-Gaussian distribution 
was observed. Area under the curves (AUC) were 
determined using the trapezoidal rule for glucose profiles 
from the 8.5 h of the nocturnal blood glucose curve.
Table 1. Clinical data of Type 1 diabetic: patients
Number 31
Sex (l:/M) 11/20
Age (yr) 40.4
119~67|
Diabetes duration (yr) 17.6
[2-571
Total insulin close (IU kg 5) 0.68 ±  0.15
NPH insulin dose (IU k g 1) 0,27 ±  0.07
NPH insulin dose (% of total dose) 40.5% ±  9.8
HbAh (%) 8,6
(6.1-11,61
Results
Results are expressed as mean ± SD or [range!.
In the first overnight blood glucose profiles from each 
of 31 patient, hypoglycaemia (defined as a blood glucose 
level <3.0 mmol I“ 1) occurred in 29% ; 67% of these 
hypoglycaemic episodes were asymptomatic; 2 patients 
woke up during the night (1 at 01.00 h and 1 at 05.00 
h) with sweating and heart pounding and 1 patient 
experienced neuroglycopenic symptoms of confusion, 
inability to concentrate and irritability before bedtime. 
The nadir of blood glucose ranged from 2.5 to 2.7 mmol 
h 1 in these symptomatic cases, whereas it ranged from 
0.9 to 2.5 mmol h 1 in the asymptomatic group. There 
were no patients with hypoglycaemic symptoms and 
blood glucose values >3.0 mmol I"1.
The distribution of nocturnal hypoglycaemia is shown 
in Figure 1, Two separate intervals of hypoglycaemia 
were observed during the night. One occurred in the 
early night from 23.00 to 01.00 h and the other in the 
early morning from 04.00 to 07.30 h. No hypoglycaemic 
episodes were noted from 01.00 to 04.00 h. There were 
5 subjects with hypoglycaemic episodes in the early 
night and 6 subjects with episodes in the early morning; 
2 patients experienced an 'early night' as well as an 
'early morning7 hypoglycaemia.
The median duration of all hypoglycaemic episodes 
was 1.0 (range 0.5—3.5) h. The median duration of the 
'early night' hypoglycaemic episodes was 1.0 (range 
0.5-1.5) h and of the 'early morning" hypoglycaemic: 
episodes 2,5 (range 0.5-3,5 h) h, p = NS.
Figure 2 shows the association between the nadir of 
blood glucose in the 'early morning' and fasting blood 
glucose levels. Linear regression showed a correlation 
coefficient of 0.98, p <  0.0001. A fasting glucose of
M was never preceded by 'early morning' 
hypoglycaemia. A fasting blood glucose level at 07,30 
h of <5,5 mmol I 1 was associated with 'early morning' 
hypoglycaemia in 6 of 12 patient-nights; in 4 cases a 
fasting glucose <3.0 mmol h ! at 07,30 h was measured.
'Early night' hypoglycaemia was already apparent at
23.00 h in 4 of 5 cases. These glucose values were ail 
taken before a bedtime snack, as were all but 6 of the
23.00 h readings. There was a significant correlation 
between bedtime glucose and the nadir of blood glucose 
in the 'early night' (correlation coefficient 0.87, p <  
0.0001) as shown in Figure 3. Bedtime glucose values
h 1 were never followed by 'early night' 
hypoglycaemia whether these glucose values were post- 
or pre-snack. In 16 subjects glucose was ^7.5 mmol I “1 
at bedtime. Nine out of 11 patients who did not 
experience an 'early night' hypoglycaemia snacked 
before sleeping. The 2 patients who did not snack before 
sleeping had a nadir of blood glucose of, respectively,
3.0 and 5.8 mmol M.
No predictive value was found for bedtime blood
5.5 mmol
>7.5 mmol
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Figure 1. Time related frequency of nocturnal hypoglycaemia
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Figure 2. Correlation between fasting blood glucose and blood glucose nadir in the 'early morning'; (Pearson) correlation coefficient 
0 .9 8 ;  p  <  0.0001
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Figure 3. Correlation between bedtime blood glucose and blood glucose nadir in the 'early night'; (Pearson) correlation coefficient 
0 .8 7 ;  p  <  0 .0001
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Table 2. Intra-individual variation of nocturnal blood glucose 
profiles in 6 diabetic patients who were observed for 20 nights
Patient
number
Nights of 
observation
AUC (CV) Number of 
hypoglycaemic 
episodes
A 5 72.7 (39%) 2
B 5 88.0 (28%) 1
C 2 86.3 (54%) 1
D 3 93.8 (14%) 0
E 3 71.6 (49%) 2
F 2 64.7 (62%) 0
Area under  curve for glucose profiles from the 8.5 h of the noctumal 
blood g lucose curve (AUC) and  coefficient of variation (CV)
mmol
glucose levels at 23.00 h with respect to 'early morning' 
hypoglycaemia. Whether there was evening-snacking or 
not, it did not influence the frequency or timing of 'early 
morning' hypoglycaemia. The mean bedtime blood 
glucose level before the nights with 'early morning' 
hypoglycaemia was 10.3 ±  4.0 mmol I"1 and 9,8 ±  6,5
h 1 before the nights without 'early morning' hypo- 
glycaemia.
Mean total daily insulin dose was 0.68 ±  0.15 IU kg"1. 
Total NPH insulin dose was 0.27 ±  0.07 IU kg"1 as 
shown in Table 1. There was a significant difference 
between NPH insulin dose in patients with 'early 
morning' hypoglycaemia, 0.32 ±  0.06 IU kg“ 1 and in 
patients without 'early morning' hypoglycaemia, 
0.26 ± 0.06 IU kg'“1 (p <  0.05), No such difference was 
found with respect to 'early night' hypoglycaemia. 
HbAh was 8.4 ± 1.4% in the group without nocturnal 
hypoglycaemia compared to 9.3 ±  1.5% in the group 
with nocturnal hypoglycaemia (p = NS).
Six subjects were observed during 20 patient-nights. 
There was a marked intra-individual variation in nocturnal 
blood glucose values as shown in Table 2. The area 
under the curve (AUC(M1.S u) ° f  nocturnal blood glucose 
curves showed a coefficient of variation ranging from 
14 to 62 %. The coefficient of variation of nocturnal 
blood glucose values at certain time points varied from 
14 to 111 % (Table 3).
Discussion
The present study shows a high frequency (29 %) of 
nocturnal hypoglycaemia, defined as a blood glucose 
level <3,0 mmol in Type 1 diabetic patients on 
multiple insulin injection regimens. This finding is in 
agreement with the one comparable study in the litera­
ture21 and with the DCCT, which showed an increase 
of 'severe' hypoglycaemia in the intensively versus 
conventionally treated subjects,6,7 In the DCCT, 43 % of 
episodes of severe hypoglycaemia occurred between 
midnight and 8 am. In our study 67 % of episodes were 
asymptomatic, in agreement with previous studies of 
nocturnal hypoglycaemia independent of insulin regimen 
used,1M0
Our study showed two clearly separated episodes of 
hypoglycaemia during the night, 'early night' hypoglycae­
mia occurring between 23,00 and 01.00 h and 'early 
morning' hypoglycaemia occurring between 04.00 and
07,30 h. None of the patients exhibited a hypoglycaemic 
episode between 01.00 and 04.00 h. 'Early night' 
hypoglycaemia most probably has to be attributed to the 
extended action of the evening dose of soluble insulin, 
whereas 'early morning' hypoglycaemia, occurring 
between 04.00 and 07.30 h, is probably due to the 
bedtime NPH insulin. Although Bendtson et aL found 
no such definitive separate intervals they stated that a 
blood sample at 03.00 h would have detected only 13 % 
of the episodes of biochemical hypoglycaemia in their 
patients on multiple insulin injections. They found a 
peak incidence of nocturnal hypoglycaemia at 04.00 h 
in their patients.21 The DCCT found that even 26 % of 
all severe hypoglycaemic events occurred between 04.00 
and 08.00 h.7
We found that 'early night' hypoglycaemia was already 
apparent at 23,00 h in all but one case. Bedtime glucose 
>7.5 mmol I"1 was not followed by an 'early night' 
hypoglycaemia. Similarly, Bendtson et al. showed that a 
bedtime blood glucose at 23.00 h <6.0 mmol !~' in 
patients on multiple insulin injections increased the risk 
of getting nocturnal hypoglycaemia to 100% .J1 No 
predictive value was found in our study for bedtime 
glucose levels with respect to 'early morning' hypoglycae­
mia but fasting blood glucose levels were strongly
Table 3. Intra-individual variation of nocturnal blood glucose values
Number Bedtime glucose Nadir night 03.00h Nadir morning Fasting glucose
A 9.5 (36%) 6.9 (59%) 9.7 (41%) 6.3 (59%) 7.5 (47%)
B 7.2 (37%) 5,9 (62%) 11.9 (30%) 10,3 (33%) 12,3 (35%)
C 12.4 (41%) 9,3 (84%) 9,3 (84%) 6.1 (104%) 7.9 (48%)
D 11.1 (55%) 10,3 (49%) 12,5 (14%) 7.5 (23%) 7.5 (23%)
E 11.2 (49%) 8.3 (50%) 8.5 (53%) 4.2 (111%) 4.5 (105%)
F 4,8 (29%) 4.8 (29%) 8,3 (60%) 6.8 (60%) 8.4 (71%)
Nocturnal b lood  glucose values at certain time-points during the night are expressed as means; coefficient of variation be tw een  brackets
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variability of the absorption of NPH insulin and theindicative of preceding 'early morning' hypoglycaemia. 
This contrasts with Bendtson's data where there was no 
significant difference between fasting blood glucose in 
patients with and without nocturnal hypoglycaemia but 
the failure to distinguish 'early night' and 'early morning' 
hypoglycaemia in the earlier study may explain the 
discrepancy. Also the more frequent sampling of blood 
in our study could be relevant, since 30% of the 'early 
morning' hypoglycaemic events lasted only 30 min. The 
overall duration of nocturnal hypoglycaemia however 
was not different in the two studies.
We found no indication of the 'Somogyi' effect in our 
study. Higher fasting blood glucose levels generally 
reflected higher blood glucose levels during the night 
and nocturnal hypoglycaemia was associated with low 
fasting blood glucose. Posthypoglycaemic insulin resist­
ance may result in rebound hyperglycaemia especially 
after breakfast.8 We did not measure blood glucose after
07.30 am but HbA1c levels did not differ between the 
hypoglycaemic and non-hypoglycaemic groups.
A marked intra-individual variation of nocturnal blood 
glucose profiles was seen in patients on different nights. 
The variable absorption of NPH insulin most likely is 
the main reason for this variation24 although fluctuations 
of glucose due to mental stress or physical activities in 
the days before the measurement may also contribute.
In extrapolating the results of this study to clinical 
practice, one has to keep in mind the inevitably artificial 
circumstances in which we made our observations. 
Nevertheless, our findings have important clinical impli­
cations. Firstly, as 'early night' hypoglycaemia appeared 
to be present already at bedtime in most instances, daily 
monitoring of bedtime glucose and taking appropriate 
action such as the intake of extra carbohydrates could 
abolish or at least attenuate 'early night' hypoglycaemia. 
Secondly, as 'early morning' hypoglycaemia was exclus­
ively associated with fasting blood glucose below 5.5 
mmol I-1, we would suggest the target value for fasting 
blood glucose levels should be slightly above this level. 
This is in contrast to the guidelines used in the DCCT 
which aimed at fasting glucose levels between 3.9 and 
6.7 mmol I“ 1. We would suggest these targets may have 
contributed to the high prevalence of severe nocturnal 
hypoglycaemia in the DCCT.67. Thirdly, the results of 
our study do not lend support to the advice in the IDDM 
consensus guidelines of weekly monitoring 03.00 am 
blood glucose.25 The chance of detecting hypoglycaemia 
in this way must be very low, even if the patient complies 
with this advice. Our data suggest that daily monitoring 
of fasting blood glucose, aiming at levels >5.5 mmol 
I-1 and taking immediate and appropriate action with 
regard to evening NPH insulin dosing could abolish 
almost all 'early morning' hypoglycaemic episodes. The 
large variation from day to day in NPH insulin absorption 
must however be remembered so that dose adjustments 
are made only after observing high fasting blood glucose 
levels on consecutive mornings over one week or more. 
Nevertheless we submit that in view of the strong
corresponding variation of fasting blood glucose levels, 
relatively high fasting blood glucose levels may have to 
be accepted from time to time to avoid nocturnal 
hypoglycaemia. Prompt correction of these values with 
extra short-acting insulin before breakfast should be 
carried out by the patient on a daily basis to reach 
overall glycaemic control as satisfactorily as possible,
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